Physician profile
Jonathan Cutler
NPI 1467400275
$10,062.73
in general payments reported to CMS, 2019-2025
30 companies · $834 in 2025
The $834 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,721 · 2020: $1,436 · 2021: $2,056 · 2022: $1,649 · 2023: $626 · 2024: $1,741 · 2025: $834.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,201.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,873.03 | 2019-2025 | Variax, Graftjacket, Prostep |
| Flower Orthopedics Coporation | $1,296.99 | 2019-2022 | |
| Horizon Therapeutics Plc | $1,163.07 | 2019-2022 | |
| Djo, LLC | $810.29 | 2019-2024 | Cmf, Chattanooga |
| Organogenesis INC. | $553.90 | 2021-2022 | |
| Integra Lifesciences Corporation | $492.47 | 2021-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Biocomposites INC | $351.00 | 2024-2025 | Stimulan |
| Medtronic, INC. | $341.36 | 2021-2022 | |
| Treace Medical Concepts, INC. | $337.05 | 2024-2025 | |
| Fusion Orthopedics USA, LLC | $230.62 | 2025 | |
| Ets Wound Care LLC | $164.57 | 2024 | Mirragen Advanced Wound Matrix |
| Smith+Nephew, INC. | $164.53 | 2019-2024 | Collagenase Santyl, Grafix Pl, Stravix |
| Amgen INC. | $161.05 | 2025 | Krystexxa |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $155.70 | 2020-2023 | Jublia |
| Wright Medical Technology, INC. | $127.59 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $124.99 | 2024 | Nuzyra |
| Convatec INC. | $117.50 | 2025 | |
| Triad Life Sciences INC. | $114.68 | 2021-2022 | |
| Embody, INC. | $78.73 | 2022 | |
| Sebela Pharmaceuticals INC. | $75.33 | 2019-2022 | |
| Trimed, INC. | $63.05 | 2020 | |
| Ani Pharmaceuticals, INC. | $53.11 | 2024-2025 | Purified Cortrophin Gel |
| Vilex LLC | $48.91 | 2024 | |
| Orthofix Medical, INC. | $39.38 | 2019-2020 | |
| Depuy Synthes Sales INC. | $31.94 | 2020 | |
| Acera Surgical, INC. | $26.87 | 2022 | |
| Electronic Waveform Lab, INC. | $22.45 | 2020-2021 | |
| Bioventus LLC | $18.61 | 2019 | |
| Merck Sharp & Dohme LLC | $16.47 | 2019 | |
| Ossdsign USA Incorporated | $7.49 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Cutler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.